Journal of Cystic Fibrosis
Volume 5, Issue 2 , Pages 77-84 , May 2006

Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis

  • Jacqueline A. Jumpsen

      Affiliations

    • Nutrition and Metabolism Research Group, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • ,
  • Neil E. Brown

      Affiliations

    • Nutrition and Metabolism Research Group, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • ,
  • Alan B.R. Thomson

      Affiliations

    • Nutrition and Metabolism Research Group, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • ,
  • S.F. Paul Man

      Affiliations

    • Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
  • ,
  • Yeow K. Goh

      Affiliations

    • Nutrition and Metabolism Research Group, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • ,
  • David Ma

      Affiliations

    • Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Canada
  • ,
  • M.T. Clandinin

      Affiliations

    • Nutrition and Metabolism Research Group, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    • Corresponding Author InformationCorresponding author. Nutrition and Metabolism Research Group, Department of Agricultural, Food and Nutritional Science, 4-10 Agriculture/Forestry Centre, University of Alberta, Edmonton, Alberta, Canada T6G 2P5. Tel.: +1 780 492 5188; fax: +1 780 492 8855.

Received 7 June 2005 ,Revised 28 December 2005 ,Accepted 9 January 2006.

References 

  1. Tizzano EF, Buchwald M. Cystic fibrosis. Beyond gene to therapy. J Pediatr. 1992;120:337–349
  2. Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H, et al. The relation between genotype and phenotype in cystic fibrosis—analysis of the most common mutation (ΔF508). N Engl J Med. 1990;323:1517–1522
  3. Farrell PM, Mischler EH, Engle MJ, Brown DJ, Lau S. Fatty acid abnormalities in cystic fibrosis. Pediatr Res. 1985;19:104–109
  4. Parsons HG, O'Loughlin EV, Forbes D, Cooper D, Gall DG. Supplemental calories improve essential fatty acid deficiency in cystic fibrosis patients. Pediatr Res. 1988;24:353–356
  5. Christophe A, Borrerecht E, De Baets F, Franckx F. Increase of long chain omega-3 fatty acids in the major serum lipid classes of patients with cystic fibrosis. Ann Nutr Metab. 1992;36:304–312
  6. Clandinin MT, Zuberbuhler P, Brown NE, Kielo ES, Goh YK. Fatty acid pool size in plasma lipoprotein fractions of cystic fibrosis patients. Am J Clin Nutr. 1995;62:1268–1275
  7. Benabdeslam H, Garcia I, Bellon G, Gilly R, Revol A. Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts. Am J Clin Nutr. 1998;67(5):912–918
  8. Christophe AB, Warwick WJ, Holman RT. Serum fatty acid profiles in cystic fibrosis patients and their parents. Lipids. 1994;29(8):569–575
  9. Lloyd-Still JD, Johnson SB, Holman RT. Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants. Am J Clin Nutr. 1991;54(6):1029–1035
  10. Roulet M, Frascarolo P, Rappaz I, Pilet M. Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur J Pediatr. 1997;156(12):952–956
  11. Underwood BA, Denning CR, Navob M. Polyunsaturated fatty acids and tocopherol levels in patients with cystic fibrosis. Ann N Y Acad Sci. 1972;203:237–247
  12. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride methanol. J Lipid Res. 1964;5:600–608
  13. Hargreaves KM, Clandinin MT. Phosphatidylethanolamine methyltransferase: evidence for influence of diet fat on selectivity of substrate for methylation in rat brain synaptic plasma membrane. Biochim Biophys Acta. 1987;918:97–105
  14. Christophe AB, Verdonk G, Robberecht E, Mahathanakhun R. Effect of supplementing medium chain triglycerides with linoleic acid-rich monoglycerides on severely disturbed serum lipid fatty acid patterns in patients with cystic fibrosis. Ann Nutr Metab. 1985;29(4):239–245
  15. Christophe AB, Robberecht E, Franckx H, DeBoets F, van dePas M. Effect of administration of gamma-linolenic acid on the fatty acid composition of serum phospholipids and cholesteryl esters in patients with cystic fibrosis. Ann Nutr Metab. 1994;38(1):40–47
  16. Strandvik B, Hultcrantz R. Liver function and morphology during long-term fatty acid supplementation in cystic fibrosis. Liver. 1994;14(1):32–36
  17. Kalivianakis M, Minich DM, Bijleveld CM, van Aalderen WM, Stellaard F, Laseur M, et al. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr. 1999;69:127–134
  18. Kang J, Brown NE, Man SFP, Labrecque P, Clandinin MT. The chloride channel blocker athracene 9-carboxylate inhibits fatty acid incorporation into phospholipid in cultured human airway epithelial cells. Biochem J. 1992;285:725–729
  19. Bhura-Bandali F, Suh M, Man SFP, Clandinin MT. The ΔF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells. J Nutr. 2000;130:2870–2875
  20. Singh I, Moser AE, Goldfischer S, Moser HW. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci U S A. 1984;81(13):4203–4207
  21. Strandvik B, Gronowitz E, Enlund F, Martinsson T, Wahlstrom J. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr. 2001;138:650–655
  22. Freedman SD, Katz MH, Parker EM, Laposata M, Urman MY, Alvarez JG. A membrane lipid imbalance plays a role in the phenotype expression of cystic fibrosis in CFTR mice. Proc Natl Acad Sci U S A. 1999;13995–14000
  23. Lloyd-Still JD, Bibus DM, Powers CA, Johnson SB, Holman RT. Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis. Acta Paediatr. 1996;85(12):1426–1432
  24. Balazy M, Murphy RC. Determination of sulfidopeptide leukotrienes in biological fluids by gas chromatography/mass spectrometry. Anal Chem. 1986;58:1098–1101
  25. Yurawecz MP, Sehat N, Mossoba MM, Roach JAG, Kramer JKG, Ku Y. Variations in isomer distribution in commercially available conjugated linoleic acid. Fett-Lipid. 1999;101:277–282
  26. Parsons H, Emken EM, Marai L, Kuksis A. Simultaneous analysis of low plasma levels of deuterium-labeled saturated and unsaturated fatty acids as t-butyldimethylsilyl esters. Lipids. 1986;21:247–251
  27. English D, Andersen BR. Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradient of ficoll-hypaque. J Immunol Methods. 1974;5:249–252
  28. Hanahan DJ, Ekholm JE. Changes in erythrocyte membranes during preparation as expressed by ATPase activity. Biochim Biophys Acta. 1972;255:413–419
  29. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem. 1957;226:497–509
  30. Touchstone JC, Chen JC, Beaver KM. Improved separation of phospholipids in thin-layer chromatography. Lipids. 1980;15:61–62
  31. van Egmond AW, Kosorok MR, Koscik R, Laxova A, Farrell PM. Effect of linoleic acid intake on growth of infants with cystic fibrosis. Am J Clin Nutr. 1996;63(5):746–752
  32. Dodge JA, Custance JM, Goodchild MC, Laing SC, Vaughan M. Paradoxical effects of essential fatty acid supplementation on lipid profiles and sweat electrolytes in cystic fibrosis. Br J Nutr. 1990;63(2):259–271
  33. Strandvik B, Svensson E, Seyberth HW. Prostanoid biosynthesis in patients with cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids. 1996;55:419–425
  34. Chase HP, Dupont J. Abnormal levels of prostaglandins and fatty acids in blood of children with cystic fibrosis. Lancet. 1978;2:236–238
  35. Stead RJ, Barradas MA, Mikhailidis DP, Hodson ME, Batten JC, Dandona P. Platelet function in patients with cystic fibrosis. Prog Lipid Res. 1986;25:305–307
  36. Kurlandsky LE, Bennink MR, Webb PM, Ulrich PJ, Boer LJ. The absorption and effect of dietary supplementation with omega-3 fatty acids on serum leukotriene B4 in patients with cystic fibrosis. Pediatr Pulmonol. 1994;18(4):211–217
  37. Hubbard VS, Dunn DG. Fatty acid composition of erythrocyte phospholipids from patients with cystic fibrosis. Clin Chim Acta. 1980;102:115–118
  38. Lloyd-Still JD, Johnson SB, Holman RT. Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation. Am J Clin Nutr. 1981;34:1–7
  39. Carlstedt-Duke J, Bronnegard M, Strandvik B. Pathological regulation of arachidonic release in cystic fibrosis: the putative basic defect. Proc Natl Acad Sci U S A. 1986;83:9202–9206
  40. Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med. 2004;350(6):560–569
  41. Freedman SD, Weinstein D, Blanco PG, Martinez-Clark P, Ulman S, Zaman M, et al. Characterization of LPS-induced lung inflammation in cftr+/− mice and the effect of docosahexaenoic acid. J Appl Physiol. 2002;92:2169–2176
  42. Beckles Willson N, Elliott TM, et al. Omega-3 fatty acids (from fish oil) for cystic fibrosis (Cochrane Review). In: The Cochrane Library, issue 1, 2003. Oxford: Update Software.
  43. Werner A, Bongers MEJ, Bijveld MJ, de Jonge HR, Verkade HJ. No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis. J Lipid Res. 2004;45:2277–2286
  44. Dombrowsky H, Clark GT, Rau GA, Bernhard W, Postle AD. Molecular species compositions of lung and pancreas phospholipids in the cftrtml HGU/tml HGU cystic fibrosis mouse. Pediatr Res. 2003;53:447–454

 Grant Support: Financial support was obtained from Martek Biosciences Corporation, MTI MetaTech Inc. and National Science and Engineering Research Council (NSERC).

PII: S1569-1993(06)00022-1

doi: 10.1016/j.jcf.2006.01.004

Journal of Cystic Fibrosis
Volume 5, Issue 2 , Pages 77-84 , May 2006